Wearable Devices Receives $750,000 Grant for Neural Rehabilitation Pilot Study

Wearable Devices Ltd. (NASDAQ: WLDS) has received approval from the Israel Innovation Authority for a $750,000 budget to support a clinical pilot program with Soroka University Medical Center. The study will evaluate the company's Mudra Link neural wristband as a rehabilitation tool for patients experiencing impaired grip-force control following motor-cortex injuries.

The importance of this development lies in the potential expansion of accessible rehabilitation technologies for neurological patients. By extending Wearable Devices' patented surface electromyography (EMG) technology into quantitative neuro-muscular monitoring, the pilot aims to improve tracking capabilities and therapeutic outcomes in force-control therapy. This represents a significant application of consumer technology to address medical rehabilitation challenges.

For the medical technology industry, this grant-funded pilot demonstrates how AI-powered wearable devices originally developed for consumer applications can be adapted for clinical purposes. The Mudra Link technology, which enables touch-free control of digital devices through neural input, is now being tested for its potential to assist patients recovering from neurological injuries. This crossover between consumer electronics and medical devices could establish new standards for rehabilitation technology.

The clinical implications are substantial for patients with motor-cortex injuries who struggle with grip-force control. Traditional rehabilitation methods often require extensive clinical supervision and specialized equipment. The Mudra Link wristband, if proven effective in the pilot study, could provide more accessible, continuous monitoring and therapy options that patients could potentially use outside clinical settings. This could lead to more personalized rehabilitation approaches and better long-term outcomes.

From a business perspective, this grant represents validation of Wearable Devices' technology by a respected innovation authority and medical institution. The company, which trades on the Nasdaq Capital Market under symbols "WLDS" and "WLDSW," specializes in AI-powered touchless sensing wearables through products like the Mudra Band and Mudra Link. The latest news and updates relating to WLDS are available in the company's newsroom at https://ibn.fm/WLDS.

The Israel Innovation Authority's support indicates confidence in the technology's potential applications beyond consumer markets. For investors and industry observers, this development suggests Wearable Devices may be positioning itself at the intersection of multiple growing technology sectors including medical devices, rehabilitation technology, and neural interface systems. The full press release about this development can be viewed at https://ibn.fm/mqAi7.

This pilot program represents a strategic expansion of Wearable Devices' technology platform into healthcare applications. The company's dual-channel business model, which includes both direct-to-consumer sales and enterprise licensing, could potentially incorporate medical rehabilitation as a new vertical. As neural interface technology continues to advance, applications in medical therapy and rehabilitation represent significant growth opportunities for companies developing these systems.